Company intelligence / Profile preview

Alkopharma

Ownership: Private
Development stage: Preclinical

Overview

Alkopharma USA operates as part of Transo-Pharm GmbH’s global network to supply high-quality Active Pharmaceutical Ingredients. The company focuses on adhering to stringent quality standards for pharmaceutical ingredients and acts primarily as a distributor or virtual booth for these products. There is no evidence that it develops its own clinical-stage therapeutics.

Modalities: Active Pharmaceutical Ingredients (APIs)
Industry: Chemicals & Materials

Drug pipeline

1 asset

Sanorex

Indications: Weight loss

Partnerships

Transo-Pharm GmbH

Beyond the preview

Go deeper on Alkopharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alkopharma.

Explore the full profile